Clonality and Genetic Divergence in Multifocal Low-Grade Superficial Urothelial Carcinoma as Determined by Chromosome 9 and p53 Deletion Analysis
暂无分享,去创建一个
Dirk Zaak | Arndt Hartmann | Wolfgang Dietmaier | R. Knuechel | A. Hartmann | F. Hofstaedter | D. Zaak | W. Dietmaier | Ruth Knuechel | Ferdinand Hofstaedter | Ursula Rösner | Gudrun Schlake | G. Schlake | U. Rösner
[1] M. Knowles,et al. A novel candidate tumour suppressor locus at 9q32-33 in bladder cancer: localization of the candidate region within a single 840 kb YAC. , 1997, Human molecular genetics.
[2] S. Lerner,et al. Role of chromosome 9 in human bladder cancer. , 1993, Cancer research.
[3] N. Sternberg,et al. Preparation and screening of an arrayed human genomic library generated with the P1 cloning system. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[4] David Sidransky,et al. Detection of bladder cancer recurrence by microsatellite analysis of urine , 1997, Nature Medicine.
[5] R. Takahashi,et al. Metachronous multifocal development of urothelial cancers by intraluminal seeding , 1993, The Lancet.
[6] K. Nomoto,et al. Prolongation of kidney graft survival by cyclophosphamide-induced tolerance in rats. , 1995, The Journal of urology.
[7] T. Sekiya,et al. Allelic loss on chromosome 9 in bladder cancer tissues and urine samples detected by blunt‐end single‐strand DNA conformation polymorphism , 1998, International journal of cancer.
[8] J. Barrett,et al. An Alu polymorphism intragenic to the TP53 gene. , 1991, Nucleic acids research.
[9] B. Czerniak,et al. Superimposed histologic and genetic mapping of chromosome 17 alterations in human urinary bladder neoplasia , 1997, Oncogene.
[10] L. Sobin,et al. TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.
[11] Kathleen R. Cho,et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours , 1995, Nature Genetics.
[12] P. Nieh,et al. Biopsy of apparently normal urothelium in patients with bladder carcinoma. , 1978, The Journal of urology.
[13] O. Yoshida,et al. Clonal and chronological genetic analysis of multifocal cancers of the bladder and upper urinary tract. , 1998, Cancer research.
[14] Georgia Lahr,et al. Identification of expressed genes by laser-mediated manipulation of single cells , 1998, Nature Biotechnology.
[15] N. Kinukawa,et al. p53 mutations in multiple urothelial carcinomas: a molecular analysis of the development of multiple carcinomas. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[16] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[17] D. Sidransky,et al. Evidence for two bladder cancer suppressor loci on human chromosome 9. , 1993, Cancer research.
[18] B. Vogelstein,et al. Clonal origin of bladder cancer. , 1992, The New England journal of medicine.
[19] F. Rousseau,et al. Four tumor suppressor loci on chromosome 9q in bladder cancer: evidence for two novel candidate regions at 9q22.3 and 9q31 , 1999, Oncogene.
[20] Harlan I. Firminger,et al. Atlas of tumor pathology , 1954 .
[21] Z. Petrovich,et al. Carcinoma of the bladder : innovations in management , 1997 .
[22] R. Cote,et al. Two molecular pathways to transitional cell carcinoma of the bladder. , 1994, Cancer research.
[23] M. Knowles,et al. Structure and methylation-based silencing of a gene (DBCCR1) within a candidate bladder cancer tumor suppressor region at 9q32-q33. , 1999, Genomics.
[24] A. Hartmann,et al. Multiple mutation analyses in single tumor cells with improved whole genome amplification. , 1999, The American journal of pathology.
[25] P. Carroll,et al. Chromosome‐9 loss detected by fluorescence in situ hybridization in bladder cancer , 1995, International journal of cancer.
[26] H Stepp,et al. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. , 1996, The Journal of urology.
[27] J. Tomaszewski,et al. Characterization of chromosome 9 deletions in transitional cell carcinoma by microsatellite assay. , 1993, Human molecular genetics.
[28] I. Petersen,et al. p53 mutations in phenacetin-associated human urothelial carcinomas. , 1993, Carcinogenesis.
[29] L. Aaltonen,et al. Semiautomated assessment of loss of heterozygosity and replication error in tumors. , 1996, Cancer research.
[30] A Hofstetter,et al. Frequent genetic alterations in simple urothelial hyperplasias of the bladder in patients with papillary urothelial carcinoma. , 1999, The American journal of pathology.
[31] Y. Bignon,et al. Human bladder cancers and normal bladder mucosa present the same hot spot of heterozygous chromosome‐9 deletion , 1998, International journal of cancer.
[32] M. Knowles,et al. Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder. , 1994, Oncogene.
[33] T. Wheldon,et al. Clonal analysis of phenacetin‐implicated urothelial carcinoma , 1995, International journal of cancer.
[34] P. Jones,et al. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations. , 1996, Cancer research.
[35] S. Rasheed,et al. A simple procedure for maximum yield of high-quality plasmid DNA. , 1990, BioTechniques.
[36] P. Nichols,et al. Mosaicism in human epithelium: macroscopic monoclonal patches cover the urothelium. , 1995, The Journal of urology.
[37] M. Soloway,et al. Rationale for intravesical chemotherapy in the treatment and prophylaxis of superficial transitional cell carcinoma. , 1989, Progress in clinical and biological research.
[38] Education in Pathology. Atlas of tumor pathology. Third series , 1991 .
[39] A. Harris,et al. Bladder cancer--field versus clonal origin. , 1992, The New England journal of medicine.
[40] R. Hruban,et al. Brief report: molecular biology and the early detection of carcinoma of the bladder--the case of Hubert H. Humphrey. , 1994, The New England journal of medicine.
[41] I. N. Reid,et al. Molecular screening of multifocal transitional cell carcinoma of the bladder using p53 mutations as biomarkers. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[42] P. Jones,et al. Molecular Genetics in Carcinoma of the Bladder , 1998 .
[43] Y S Erozan,et al. Molecular Detection of Primary Bladder Cancer by Microsatellite Analysis , 1996, Science.
[44] D. Neal,et al. c-erbB-2 amplification and identical p53 mutations in concomitant transitional carcinomas of renal pelvis and urinary bladder , 1992, The Lancet.
[45] W. Catalona,et al. Urothelial Tumors of the Urinary Tract , 1992 .